We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+15.12%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$487M
AUM Growth
-$3.25B
Cap. Flow
-$3.3B
Cap. Flow %
-678.55%
Top 10 Hldgs %
60.08%
Holding
635
New
80
Increased
47
Reduced
54
Closed
377

Top Buys

Rank Stock Value
1
XBP icon
XBP Global Holdings
XBP
+$91.7M
2
GSK icon
GSK
GSK
+$22.6M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.82M
4
CYTK icon
Cytokinetics
CYTK
+$7.14M
5
TSLA icon
Tesla
TSLA
+$6.42M

Sector Composition

Rank Sector Weight
1 Financials 21.01%
2 Technology 14.12%
3 Healthcare 12.63%
4 Communication Services 9.2%
5 Consumer Discretionary 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCSAW
201
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$12.5K ﹤0.01%
249,700
AILEW
202
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$11.4K ﹤0.01%
140,200
FOXO
203
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$11.1K ﹤0.01%
9,572
+8,615
+900% +$101K
PPYAW
204
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$11K ﹤0.01%
550,000
APVO icon
205
Aptevo Therapeutics
APVO
$5.25M
0
LDTCW
206
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$8.57K ﹤0.01%
100,834
HSCS icon
207
Heart Test Laboratories
HSCS
$7.44M
$8.55K ﹤0.01%
+500
New +$12.3K
CEROW
208
DELISTED
CERo Therapeutics Warrants
CEROW
$8.54K ﹤0.01%
363,548
CLOER
209
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$8.48K ﹤0.01%
49,900
BAERW icon
210
Bridger Aerospace Warrant
BAERW
$13.2M
$8.48K ﹤0.01%
40,113
ABPWW
211
DELISTED
Abpro Holdings Warrant
ABPWW
$7.54K ﹤0.01%
375,000
ELBM
212
Electra Battery Materials
ELBM
$54.8M
$7.3K ﹤0.01%
+5,000
New +$9.46K
TLSA icon
213
Tiziana Life Sciences
TLSA
$123M
$6.77K ﹤0.01%
12,091
ALCYW
214
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$5.89K ﹤0.01%
39,300
+300
+0.8% +$52
CCGWW
215
Cheche Group Inc Warrant
CCGWW
$256K
$5.69K ﹤0.01%
101,608
CVIIW
216
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$5.66K ﹤0.01%
43,481
SUNW
217
DELISTED
Sunworks, Inc.
SUNW
$4.93K ﹤0.01%
+21,000
New +$7.14K
WKHS icon
218
Workhorse Group
WKHS
$32.4M
$4.61K ﹤0.01%
4
BNZIW icon
219
Banzai International Warrant
BNZIW
$126K
$4.59K ﹤0.01%
100,000
SVIIR
220
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$4.16K ﹤0.01%
29,690
SATX.WS.A
221
DELISTED
SatixFy Communications Ltd.
SATX.WS.A
$4K ﹤0.01%
500,000
SDSTW
222
Stardust Power Inc Warrant
SDSTW
$4.71M
$3.98K ﹤0.01%
158,540
ESHAR
223
DELISTED
ESH Acquisition Corp Right
ESHAR
$3.94K ﹤0.01%
+35,804
New +$5.37K
MMAT
224
DELISTED
Meta Materials Inc. Common Stock
MMAT
$3.3K ﹤0.01%
500
LSBPW
225
DELISTED
LakeShore Biopharma Warrants
LSBPW
$2.92K ﹤0.01%
76,931

Similar funds

Cantor Fitzgerald's Q4 2023 Portfolio in Review

As of Q4 2023, Cantor Fitzgerald held 635 positions worth $487M, down 87% from $3.74B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Cantor Fitzgerald withdrew a net $3.3B in Q4 2023, closing 377 positions and reducing 54 holdings. Its most notable exit was Apple, an estimated $98.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in XBP Global Holdings worth $35M.

  • Cantor Fitzgerald's largest Q4 2023 buy was XBP Global Holdings: 660,190 shares worth $35M.
  • Cantor Fitzgerald added most to GSK in Q4 2023, an estimated $22.6M increase.
  • Cantor Fitzgerald's biggest Q4 2023 reduction was Microsoft, cutting an estimated $109M.
  • Cantor Fitzgerald fully exited Apple in Q4 2023, selling an estimated $98.7M.
  • Cantor Fitzgerald's ten largest holdings make up 60% of its $487M portfolio in Q4 2023.
  • Cantor Fitzgerald opened 80 new positions and closed 377 in Q4 2023.
  • Cantor Fitzgerald's portfolio value fell 87% quarter-over-quarter to $487M.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.